Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases

Overview

Journal PPAR Res

Publisher Wiley

Date 2021 Aug 16

PMID 34394332

Citations 9

Authors

Somayye Taghvaei

Leila Saremi

Sepideh Babaniamansour

Affiliations

Soon will be listed here.

Abstract

Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PPARGC1A) regulates the expression of energy metabolism's genes and mitochondrial biogenesis. The essential roles of PPARGC1A encouraged the researchers to assess the relation between metabolism-related diseases and its variants. To study Gly482Ser (+1564G/A) single-nucleotide polymorphism (SNP) after PPARGC1A modeling, we substitute Gly482 for Ser482. Stability prediction tools showed that this substitution decreases the stability of PPARGC1A or has a destabilizing effect on this protein. We then utilized molecular dynamics simulation of both the Gly482Ser variant and wild type of the PPARGC1A protein to analyze the structural changes and to reveal the conformational flexibility of the PPARGC1A protein. We observed loss flexibility in the RMSD plot of the Gly482Ser variant, which was further supported by a decrease in the SASA value in the Gly482Ser variant structure of PPARGC1A and an increase of H-bond with the increase of -sheet and coil and decrease of turn in the DSSP plot of the Gly482Ser variant. Such alterations may significantly impact the structural conformation of the PPARGC1A protein, and it might also affect its function. It showed that the Gly482Ser variant affects the PPARGC1A structure and makes the backbone less flexible to move. In general, molecular dynamics simulation (MDS) showed more flexibility in the native PPARGC1A structure. Essential dynamics (ED) also revealed that the range of eigenvectors in the conformational space has lower extension of motion in the Gly482Ser variant compared with WT. The Gly482Ser variant also disrupts PPARGC1A interaction. Due to this single-nucleotide polymorphism in PPARGC1A, it became more rigid and might disarray the structural conformation and catalytic function of the protein and might also induce type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), and nonalcoholic fatty liver disease (NAFLD). The results obtained from this study will assist wet lab research in expanding potent treatment on T2DM.

Citing Articles

Role of the Gene and Its rs8192678 Polymorphism on Sport Performance, Aerobic Capacity, Muscle Adaptation and Metabolic Diseases: A Narrative Review.

Varillas-Delgado D Genes (Basel). 2025; 15(12.

PMID: 39766897 PMC: 11675316. DOI: 10.3390/genes15121631.

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction.

Tian D, Li J, Lai X, Yang Q, Zhang Z, Deng F Genes Dis. 2025; 12(2):101249.

PMID: 39759113 PMC: 11696767. DOI: 10.1016/j.gendis.2024.101249.

The rs17782313 polymorphism near MC4R gene confers a high risk of obesity and hyperglycemia, while PGC1α rs8192678 polymorphism is weakly correlated with glucometabolic disorder: a systematic review and meta-analysis.

Zhang Y, Li S, Nie H, Wang X, Li X, Wen J Front Endocrinol (Lausanne). 2023; 14:1210455.

PMID: 37621650 PMC: 10445758. DOI: 10.3389/fendo.2023.1210455.

Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening.

Taghvaei S, Taghvaei A, Anvar M, Guo C, Sabouni F, Minuchehr Z Front Pharmacol. 2023; 14:1144632.

PMID: 37502217 PMC: 10368881. DOI: 10.3389/fphar.2023.1144632.

Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function.

Ali S, Ali U, Qamar A, Zafar I, Yaqoob M, Ain Q Front Chem. 2023; 11:1173624.

PMID: 37153521 PMC: 10160440. DOI: 10.3389/fchem.2023.1173624.

References

Lemberger T, Desvergne B, Wahli W . Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol. 1996; 12:335-63. DOI: 10.1146/annurev.cellbio.12.1.335. View

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

Kumar S U, R B, Kumar D T, George Priya Doss C, Zayed H . Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach. J Biomol Struct Dyn. 2020; 40(4):1571-1585. DOI: 10.1080/07391102.2020.1830177. View

Yoon J, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J . Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001; 413(6852):131-8. DOI: 10.1038/35093050. View

Rajendran V, Purohit R, Sethumadhavan R . In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids. 2011; 43(2):603-15. DOI: 10.1007/s00726-011-1108-7. View

Kumar A, Rajendran V, Sethumadhavan R, Purohit R . Computational investigation of cancer-associated molecular mechanism in Aurora A (S155R) mutation. Cell Biochem Biophys. 2013; 66(3):787-96. DOI: 10.1007/s12013-013-9524-9. View

Yang J, Zhang Y . I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015; 43(W1):W174-81. PMC: 4489253. DOI: 10.1093/nar/gkv342. View

Bhatta P, Bermano G, Williams H, Knott R . Meta-analysis demonstrates Gly482Ser variant of PPARGC1A is associated with components of metabolic syndrome within Asian populations. Genomics. 2019; 112(2):1795-1803. DOI: 10.1016/j.ygeno.2019.10.011. View

Cheng J, Randall A, Baldi P . Prediction of protein stability changes for single-site mutations using support vector machines. Proteins. 2005; 62(4):1125-32. DOI: 10.1002/prot.20810. View

10.

Udhaya Kumar S, Kumar D, Siva R, George Priya Doss C, Zayed H . Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer. Front Bioeng Biotechnol. 2020; 7:391. PMC: 6927934. DOI: 10.3389/fbioe.2019.00391. View

11.

Tang H, Thomas P . PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics. 2016; 32(14):2230-2. DOI: 10.1093/bioinformatics/btw222. View

12.

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

13.

Kumar S U, Kumar D T, R S, C G, Zayed H . An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia. Comput Biol Med. 2020; 117:103583. DOI: 10.1016/j.compbiomed.2019.103583. View

14.

Rodrigues C, Pires D, Ascher D . DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018; 46(W1):W350-W355. PMC: 6031064. DOI: 10.1093/nar/gky300. View

15.

Barroso I, Luan J, Sandhu M, Franks P, Crowley V, Schafer A . Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia. 2006; 49(3):501-5. DOI: 10.1007/s00125-005-0130-2. View

16.

Khan I, Ansari I, Singh P, Febin Prabhu Dass J, Khan F . Identification and characterization of functional single nucleotide polymorphisms (SNPs) in Axin 1 gene: a molecular dynamics approach. Cell Biochem Biophys. 2017; 76(1-2):173-185. DOI: 10.1007/s12013-017-0818-1. View

17.

Esterbauer H, Oberkofler H, Krempler F, Patsch W . Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics. 1999; 62(1):98-102. DOI: 10.1006/geno.1999.5977. View

18.

Kumar A, Purohit R . Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain. PLoS One. 2013; 8(5):e64364. PMC: 3669323. DOI: 10.1371/journal.pone.0064364. View

19.

Portillo-Sanchez P, Cusi K . Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus. Clin Diabetes Endocrinol. 2017; 2:9. PMC: 5471954. DOI: 10.1186/s40842-016-0027-7. View

20.

Lai C, Tucker K, Parnell L, Adiconis X, Garcia-Bailo B, Griffith J . PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes. 2007; 57(4):809-16. PMC: 2519884. DOI: 10.2337/db07-1238. View